Researches show that regular exposure to the bladder medication Elmiron® causes vision problems.
Janssen Pharmaceuticals failed to warn about the eye damage risks that are associated with Elmiron® usage.
Hundreds already joined the lawsuit and may be eligible for compensation
5 separate research studies conducted in 2018 and 2019 show a clear connection between users of Elmiron® and retinal damage of the eyes. Specifically, pigmentary maculopathy. Janssen Pharmaceuticals, the makers of Elmiron®, did not use a warning label about the risks of vision loss. Due to lack of information, many people may have been mis-diagnosed over the years because the symptoms of pigmentary maculopathy match very well to other well known retinal conditions.
Find out if you are eligible for compensation.
Our dedicated team will reach out to you and walk you through the process.
If eligible, join a lawsuit with full support from our legal partners.
We begin by reviewing your online survey. First, we will look at the circumstances of your case and evaluate the actions needed.
Our support team members will follow up with you with more detailed questions about your case (for example, your or your loved ones' experience with Elmiron® and the medical history) and explain to you what you can expect throughout the process.
If eligible, we will send you a contingency fee agreement to get represented in the case by one of our leading legal partners. Fees are payable only if a lawsuit is successful or results in a favorable settlement in which you get compensation.
Hundreds of people have filed claims against Janssen Pharmaceuticals for failing to disclose the risks of vision damage and blindness from taking Elmiron and the number is growing daily.
Elmiron (pentosan polysulfate sodium) is the only drug approved in the United States to treat interstitial cystitis, which causes chronic pain in the bladder and pelvis area and affects mostly women. It is believed that hundreds of thousands of people have taken the drug and may have been exposed to the risk of potentially permanent vision damage.
Maculopathy is an eye disorder affecting the macula (the central part of the retina associated with highly sensitive vision) that can lead to blindness. There are different types of Maculopathy but according to the research of Elmiron usage “pigmentary maculopathy of unknown etiology.” is the specific type associated with users of the medication. The most common symptoms of the condition are: difficulty reading, difficulty adapting to dim lighting or darkness , distorted vision, vision dimming, and difficulty seeing objects that are close.
There is no cost involved to complete the pre-qualification and eligibility processes. Moreover, there are no fees involved with signing with the legal team. The legal team is only compensated when a successful judgment or settlement is handed down in favor of the plaintiff.
If an individual took the medication Elmiron and has been diagnosed with pigmentary maculopathy, blindness, or age-related macular degeneration they may be entitled to compensation. There are more qualifying criteria that will be discussed confidentially with a team member after the online pre-qualification evaluation.
Select Justice empowers people who were medically harmed from Elmiron usage to seek justice through informative advice and support. In addition, Select Justice helps people through the process of joining lawsuits to pursue compensation related to their medical claims and suffering.
Select Justice is a group of investigators and technology professionals who are committed to bringing justice and help to people who are suffering from serious injuries. For over 12 years, we have built a network of legal partners and advisors that are devoted to helping individuals unite and fight against dishonest corporations by holding wrongdoers accountable for their unethical behavior
A contingency fee agreement is a legal fee agreement where a client only pays an attorney if the attorney is successful in recovering compensation on the client’s behalf. Under a contingency fee agreement, an attorney works on a case for a fixed percentage of any recovery paid to the client. The contingency fee percentage can vary from state to state and by the complexity of the legal matter but is typically 33% to 40% of the compensation received by the client. Under a contingency fee agreement, the client does not pay an attorney any up-front or on-going legal fees, and the client is not responsible for any legal fees if the attorney does not obtain compensation for the client.
We take matters of personal privacy very seriously. When you share you personal and private information with our team of professionals, we take many special measures to protect your privacy. We are HIPAA-compliant to ensure any medical records you share with us are secure. Additionally, we follow other best practices in the areas of information security to assure your information is safe from prying eyes.
No, Select Justice is not a law firm and is not qualified to give any legal advice. We advocate for those individuals who have been harmed or injured by assisting them with understanding the cause of their situation, identifying who may be responsible, and helping them take steps to pursue justice against the wrongdoers.